Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00248664 · ClinicalTrials.gov registry record

Events Preceding Interstitial Cystitis (EPIC)

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
400
Enrollment target

NCT00248664 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 400 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00248664 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

EPIC is a case/control study that seeks to identify the risk factors for interstitial cystitis by comparing the experiences and medical histories of 400 women who recently developed IC with 400 similar people who do not have the disease.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2004-03
Est. Completion 2008-11

What the Registry Record Tells You About NCT00248664

The ClinicalTrials.gov registry entry for NCT00248664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00248664 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00248664 about?

NCT00248664 is a clinical study titled "Events Preceding Interstitial Cystitis (EPIC)". EPIC is a case/control study that seeks to identify the risk factors for interstitial cystitis by comparing the experiences and medical histories of 400 women who recently developed IC with 400 similar people who do not have the disease.

What is the current status of trial NCT00248664?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2004-03. Estimated completion is 2008-11.

Who is sponsoring clinical trial NCT00248664?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.